Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2014
11/27/2014US20140350034 Aminopyridine derivatives as plasma kallikrein inhibitors
11/27/2014US20140350030 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same
11/27/2014US20140350016 Potent and selective inhibitors of hepatitis c virus
11/27/2014US20140350015 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
11/27/2014US20140350014 Compounds for inhibiting the interaction of bcl2 with binding partners
11/27/2014US20140350013 Indazoles
11/27/2014US20140350012 Piperidine/piperazine derivatives
11/27/2014US20140349997 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349996 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/27/2014US20140349989 Compounds and therapeutic uses thereof
11/27/2014US20140349987 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
11/27/2014US20140349986 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
11/27/2014US20140349973 Metalloenzyme inhibitor compounds
11/27/2014US20140349368 Potent non-urea inhibitors of soluble epoxide hydrolase
11/27/2014US20140348880 Ortho-Aminothiophenol Compounds and Uses Thereof
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/25/2014US8895755 Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
11/25/2014US8895749 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
11/25/2014US8895747 Method and substances for preparation of N-substituted pyridinium compounds
11/25/2014US8895726 Compounds derived from indole and pharmaceutical compositions containing them
11/25/2014US8895647 Sterically hindered amine stabilizer
11/25/2014US8895600 Non peptidic 14-3-3 inhibitors and the use thereof
11/25/2014US8895596 Cyclic benzimidazole derivatives useful as anti-diabetic agents
11/25/2014US8895589 Pyridinyl amides as P2X3 and P2X2/3 inhibitors
11/25/2014US8895588 Pyrazole compound
11/25/2014US8895586 Methods of treating emesis
11/25/2014US8895584 Inhibitors of c-fms kinase
11/25/2014US8895583 Soluble guanylate cyclase activators
11/25/2014US8895582 Certain chemical entities, compositions, and methods
11/25/2014US8895578 Carboxamide, sulfonamide and amine compounds and methods for using the same
11/25/2014US8895574 Benzyloxypyrimidine derivative, agricultural/ horticultural insecticide comprising derivative and method for using same
11/25/2014US8895573 Phenoxy-substituted pyrimidines as opioid receptor modulators
11/25/2014US8895571 Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
11/25/2014US8895566 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
11/25/2014US8895562 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
11/25/2014US8895559 Quinoxalines derivatives and pharmaceutical compositions and kits
11/25/2014US8895558 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
11/25/2014US8895556 Compounds and method for treatment of cancer
11/25/2014US8895551 Acrylamide compounds and the use thereof
11/25/2014US8895549 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/25/2014US8895545 Acrylamide derivatives as Fab I inhibitors
11/25/2014US8895535 Pyrrolidinones as MetAP-2 inhibitors
11/25/2014US8895035 Alkoxyimino derivative and pest control agent
11/20/2014US20140343286 Anti-viral compounds
11/20/2014US20140343278 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343277 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343106 Sodium Salt Of (R)-3-[6-Amino-Pyridin-3-Yl]-2-(1-Cyclohexyl-1H-Imidazol-4-Yl)-Propionic Acid
11/20/2014US20140343103 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
11/20/2014US20140343102 Crystalline forms of the sodium salt of (4--cyclohexyl)-acetic acid
11/20/2014US20140343094 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/20/2014US20140343093 Compounds for inhibiting the interaction of bcl2 with binding partners
11/20/2014US20140343087 Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
11/20/2014US20140343086 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/20/2014US20140343083 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343075 Piperidine and piperazine derivatives as autotaxin inhibitors
11/20/2014US20140343070 Proton pump inhibitors
11/20/2014US20140343068 Certain chemical entities, compositions, and methods
11/20/2014US20140343065 New Somatostatin receptor subtype 4 (SSTR4) agonists
11/20/2014US20140343061 1,3,5 -Triazine-2-Amine Derivatives, Preparation Thereof And Diagnostic And Therapeutic Use Thereof
11/20/2014US20140343059 Novel piperazines, pharmaceutical compositions and methods of use thereof
11/20/2014US20140343042 Nicotine receptor targeted compounds and compositions
11/20/2014US20140343038 1,2,4-triazine-6-carboxamide derivative
11/20/2014US20140343037 Benzene, pyridine, and pyridazine derivatives
11/20/2014US20140343036 Isoquinoline and naphthyridine derivatives
11/20/2014US20140343031 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents
11/20/2014US20140343029 Novel Imidazole Amines as Modulators of Kinase Activity
11/20/2014US20140343018 Anti-depression Compounds
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140342906 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/18/2014US8889878 Haloalky-substituted amides as insecticides and acaricides
11/18/2014US8889874 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
11/18/2014US8889873 Process for the preparation of enantiomerically enriched proton pump inhibitors
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889866 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
11/18/2014US8889863 Stereoselective methods, catalysts and intermediates for the synthesis of (−)-Nutlin-3 and related compounds
11/18/2014US8889741 Cycloalkane derivatives
11/18/2014US8889732 Fused heterocyclic compounds and thrombopoietin receptor activators
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889720 Non-flushing niacin analogues, and methods of use thereof
11/18/2014US8889716 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/18/2014US8889715 Substituted pyridoxine-lactam carboxylate salts
11/18/2014US8889714 3,4-substituted piperidine derivatives as renin inhibitors
11/18/2014US8889712 IAP antagonists
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889704 Triazolopyridine compounds as PIM kinase inhibitors
11/18/2014US8889703 Inhibitors of beta-secretase
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889699 5-fluorouracil derivative
11/18/2014US8889698 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2014US8889695 Quinazolinone compounds
11/18/2014US8889692 Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses
11/18/2014US8889690 TRPV1 antagonists including dihydroxy substituent and uses thereof
11/18/2014US8889689 Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/18/2014US8889683 Substituted quinoxalines as inhibitors of fatty acid binding protein
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 1080